16-18793431-C-CT
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBA1
The NM_015161.3(ARL6IP1):c.494-62_494-61insA variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0355 in 605,932 control chromosomes in the GnomAD database, including 7 homozygotes. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0052 ( 7 hom., cov: 0)
Exomes 𝑓: 0.045 ( 0 hom. )
Consequence
ARL6IP1
NM_015161.3 intron
NM_015161.3 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.236
Genes affected
ARL6IP1 (HGNC:697): (ADP ribosylation factor like GTPase 6 interacting protein 1) This gene belongs to the ARL6ip family and encodes a transmembrane protein that is predominantly localized to intracytoplasmic membranes. It is highly expressed in early myeloid progenitor cells and thought to be involved in protein transport, membrane trafficking, or cell signaling during hematopoietic maturation. Mutations in this gene are associated with spastic paraplegia 61 (SPG61). Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Sep 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 16-18793431-C-CT is Benign according to our data. Variant chr16-18793431-C-CT is described in ClinVar as [Likely_benign]. Clinvar id is 1300711.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAdExome4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0631 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARL6IP1 | NM_015161.3 | c.494-62_494-61insA | intron_variant | ENST00000304414.12 | NP_055976.1 | |||
ARL6IP1 | NM_001313858.1 | c.407-62_407-61insA | intron_variant | NP_001300787.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARL6IP1 | ENST00000304414.12 | c.494-62_494-61insA | intron_variant | 1 | NM_015161.3 | ENSP00000306788 | P1 | |||
ARL6IP1 | ENST00000563861.5 | c.*76-62_*76-61insA | intron_variant, NMD_transcript_variant | 1 | ENSP00000456596 | |||||
ARL6IP1 | ENST00000546206.6 | c.407-62_407-61insA | intron_variant | 2 | ENSP00000440048 | |||||
ARL6IP1 | ENST00000562819.5 | c.149-62_149-61insA | intron_variant | 5 | ENSP00000457372 |
Frequencies
GnomAD3 genomes AF: 0.00517 AC: 724AN: 140098Hom.: 7 Cov.: 0
GnomAD3 genomes
AF:
AC:
724
AN:
140098
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0446 AC: 20758AN: 465850Hom.: 0 AF XY: 0.0444 AC XY: 10771AN XY: 242406
GnomAD4 exome
AF:
AC:
20758
AN:
465850
Hom.:
AF XY:
AC XY:
10771
AN XY:
242406
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00518 AC: 726AN: 140082Hom.: 7 Cov.: 0 AF XY: 0.00496 AC XY: 335AN XY: 67494
GnomAD4 genome
AF:
AC:
726
AN:
140082
Hom.:
Cov.:
0
AF XY:
AC XY:
335
AN XY:
67494
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 16, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at